Proton therapy during pregnancy: experimental assessment of fetal doses

Marijke De Saint-Hubert; Hrvoje Brkic; Dawid Krzempek; Natalia Mojzeszek; Mladen Kasabasic; Jacek (Jan) Gajewski; Damian Borys; Katarzyna Krzempek; Monika Lipa; G. Foltynska; Monika Radolińska; Tomasz Skóra; Olivier Van Hoey; Liliana Stolarczyk; Renata Kopec

Proton therapy during pregnancy: experimental assessment of fetal doses

Marijke De Saint-Hubert, Hrvoje Brkic, Dawid Krzempek, Natalia Mojzeszek, Mladen Kasabasic, Jacek (Jan) Gajewski, Damian Borys, Katarzyna Krzempek, Monika Lipa, G. Foltynska, Monika Radolińska, Tomasz Skóra, Olivier Van Hoey, Liliana Stolarczyk, Renata Kopec

Research output

4 Downloads (Pure)

Abstract

BACKGROUND
Proton therapy (PT) can reduce dose to healthy tissues and improve cancer treatment during pregnancy. Still only few data exist of PT during pregnancy. Besides the need to use pregnant anthropomorphic phantoms, dedicated dosimetry equipment is needed to assess fetal dose in a mixed field of radiation dominated by neutrons. Furthermore, Monte Carlo (MC) simulations are critical in the fetal dose characterization and for personalized dosimetry.

Original language	English
Number of pages	1
State	Published - 11 May 2024
Event	2024 - PTCOG: 62nd annual PTCOG conference & 4th PTCOG-AO meeting - Duration: 10 Jun 2024 → 15 Jun 2024 Conference number: PTCOG62

Conference

Conference	2024 - PTCOG
Country/Territory	Singapore
Period	2024-06-10 → 2024-06-15

Access to Document

Proton therapy during pregnancy: experimental assessment of fetal doses.pdfFinal published version, 302 KBLicense: Other

Cite this

@conference{b31d2e2b3f4945a9989a2c5feda5309d,

title = "Proton therapy during pregnancy: experimental assessment of fetal doses",

abstract = "BACKGROUNDProton therapy (PT) can reduce dose to healthy tissues and improve cancer treatment during pregnancy. Still only few data exist of PT during pregnancy. Besides the need to use pregnant anthropomorphic phantoms, dedicated dosimetry equipment is needed to assess fetal dose in a mixed field of radiation dominated by neutrons. Furthermore, Monte Carlo (MC) simulations are critical in the fetal dose characterization and for personalized dosimetry. ",

keywords = "Proton therapy, Pregnancy",

author = "{De Saint-Hubert}, Marijke and Hrvoje Brkic and Dawid Krzempek and Natalia Mojzeszek and Mladen Kasabasic and Gajewski, {Jacek (Jan)} and Damian Borys and Katarzyna Krzempek and Monika Lipa and G. Foltynska and Monika Radoli{\'n}ska and Tomasz Sk{\'o}ra and {Van Hoey}, Olivier and Liliana Stolarczyk and Renata Kopec",

note = "Score=1 ; 2024 - PTCOG : 62nd annual PTCOG conference & 4th PTCOG-AO meeting ; Conference date: 10-06-2024 Through 15-06-2024",

year = "2024",

month = may,

day = "11",

language = "English",

}

TY - CONF

T1 - Proton therapy during pregnancy

T2 - 2024 - PTCOG

AU - De Saint-Hubert, Marijke

AU - Brkic, Hrvoje

AU - Krzempek, Dawid

AU - Mojzeszek, Natalia

AU - Kasabasic, Mladen

AU - Gajewski, Jacek (Jan)

AU - Borys, Damian

AU - Krzempek, Katarzyna

AU - Lipa, Monika

AU - Foltynska, G.

AU - Radolińska, Monika

AU - Skóra, Tomasz

AU - Van Hoey, Olivier

AU - Stolarczyk, Liliana

AU - Kopec, Renata

N1 - Conference code: PTCOG62

PY - 2024/5/11

Y1 - 2024/5/11

N2 - BACKGROUNDProton therapy (PT) can reduce dose to healthy tissues and improve cancer treatment during pregnancy. Still only few data exist of PT during pregnancy. Besides the need to use pregnant anthropomorphic phantoms, dedicated dosimetry equipment is needed to assess fetal dose in a mixed field of radiation dominated by neutrons. Furthermore, Monte Carlo (MC) simulations are critical in the fetal dose characterization and for personalized dosimetry.

AB - BACKGROUNDProton therapy (PT) can reduce dose to healthy tissues and improve cancer treatment during pregnancy. Still only few data exist of PT during pregnancy. Besides the need to use pregnant anthropomorphic phantoms, dedicated dosimetry equipment is needed to assess fetal dose in a mixed field of radiation dominated by neutrons. Furthermore, Monte Carlo (MC) simulations are critical in the fetal dose characterization and for personalized dosimetry.

KW - Proton therapy

KW - Pregnancy

UR - https://ecm.sckcen.be/OTCS/llisapi.dll/open/89339159

M3 - Poster

Y2 - 10 June 2024 through 15 June 2024

ER -